*ST Green Health Co., Ltd.

Announcement on Shareholders Reducing Holdings Below 5%

Simplified Equity Change Report (Xiamen Trust)

Special Verification Opinion on Issues Related to Inquiry Letter for 2025 Annual Report of Lvkang Biochemical Co., Ltd.

Special Explanation from Lixin Certified Public Accountants (Special General Partnership) Regarding Inquiry Letter for 2025 Annual Report of Lvkang Biochemical Co., Ltd.

Announcement from Lvkang Biochemical Co., Ltd. Regarding Response to Inquiry Letter for 2025 Annual Report

Announcement on Withdrawal of Risk Warning for Stock Trading and Other Risk Warnings and Resumption of Stock Trading

Announcement on Release of Frozen Shares by Shareholders Holding More than 5%

Announcement on the Completion of Business Registration Changes

Pre-Disclosure Announcement on the Reduction of Shares by Shareholders Holding More than 5%

Announcement on the Freezing of Shares of Shareholders Holding More than 5%

Announcement on Changing the Securities Affairs Representative

Resolution Announcement of the 34th (Temporary) Meeting of the 5th Board of Directors

2026 Q1 Report

Legal Opinion on the 2025 Annual Shareholders' Meeting of Green Kang Biotechnology Co., Ltd.

Announcement of the Resolutions of the 2025 Annual Shareholders' Meeting

Announcement on the Completion of the Share Reduction Plan by Shareholders Holding More Than 5% of Shares

Progress Announcement on Applying to SZSE for Withdrawal of Delisting Risk Warning and Other Risk Warnings

Zheshang Securities Co., Ltd. 2025 Annual Continuous Supervision Opinion on the Major Asset Sale and Connected Transaction of Greenleaf Biotech Co., Ltd.

Announcement on the Freezing of Some Shares Held by Shareholders Holding 5% or More of Shares

Independent Director's 2025 Performance Report (Zhang Pengdong)

Independent Director's 2025 Performance Report (Di Yang, resigned)

Independent Director's 2025 Performance Report (Zhao Kehui, resigned)

Independent Director's 2025 Performance Report (Lu Hong, resigned)

Independent Director's 2025 Performance Report (Wang Shuang, resigned)

Independent Director's 2025 Performance Report (Cai Wenwu)

Independent Director's 2025 Performance Report (Fang Jixin)

2025 Corporate Social Responsibility Report

Internal Control Audit Report

Company's 2025 Annual Self-Evaluation Report on Internal Control

Rules of Procedure for Board Meetings

Announcement on Amending the Articles of Association and Related Systems

Articles of Association

Comparison Table of Amendments to the Articles of Association

Remuneration Management System for Directors and Senior Management

Rules of Procedure for Shareholders' Meetings

Announcement on the Company's Uncovered Losses Reaching One-Third of the Total Paid-in Capital

Announcement on Change of Accounting Policies

Announcement on Provision for Asset Impairment in 2025

Notice of Convening the 2025 Annual General Meeting of Shareholders

Announcement of Resolutions of the 33rd Meeting of the Fifth Board of Directors

Company's 2026 Director Remuneration Plan

Company's 2026 Senior Management Remuneration Plan

2025 Annual Board of Directors' Work Report

Lvkang Biochemical Co., Ltd. 2025 Annual Financial Statements

Announcement on the Company's Proposed Non-Distribution of Profits for 2025

Special Explanation on the Elimination of Non-Standard Audit Opinion Matters in the Previous Year

Assurance Report on Revenue Deduction Table

Company's 2025 Annual Accounting Firm Performance Evaluation Report

Company's 2025 Annual Audit Committee Report on Fulfilling Supervision Responsibilities

Special Report on Related Party Fund Occupation

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions

Special Report on Self-Inspection of Independence of Independent Directors

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Announcement on Application for Removal of Delisting Risk Warning and Other Risk Warnings

Announcement on the Progress of the Company Receiving Land Acquisition Compensation

Announcement on the Postponement of the Disclosure of the 2025 Annual Report

Third Risk Warning Announcement Regarding Possible Termination of Listing of Shares

Shanghai Chengming Zezheng Law Firm's Legal Opinion on Green Health Biochemical Co., Ltd.'s Second Extraordinary General Meeting of Shareholders in 2026

Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders in 2026